ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NLTX Neoleukin Therapeutics Inc

3.49
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Neoleukin Therapeutics Inc NLTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.49 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.49 3.49
more quote information »

Recent News

Date Time Source Heading
6/03/202406:31EDGAR2Form 8-K - Current report
5/10/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/10/202406:31EDGAR2Form 8-K - Current report
5/07/202405:20EDGAR2Form 8-K - Current report
4/26/202413:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
4/26/202413:33EDGAR2Form ARS - Annual Report to Security Holders
4/26/202413:33EDGAR2Form DEF 14A - Other definitive proxy statements
4/22/202415:44EDGAR2Form 8-K - Current report
4/02/202414:43EDGAR2Form 8-K - Current report
3/18/202415:10EDGAR2Form 8-K - Current report
3/18/202415:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/14/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/14/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/14/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:29EDGAR2Form 144 - Report of proposed sale of securities
3/04/202417:20EDGAR2Form 144 - Report of proposed sale of securities
3/04/202406:30EDGAR2Form 8-K - Current report
2/21/202415:07EDGAR2Form 8-K - Current report
2/20/202415:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/14/202417:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202415:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202414:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202408:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:18EDGAR2Form 144 - Report of proposed sale of securities
1/18/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/05/202406:11EDGAR2Form 8-K - Current report
12/26/202317:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/26/202317:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/26/202317:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/26/202317:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/26/202317:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/22/202315:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/21/202315:05EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12/19/202306:31EDGAR2Form 8-K - Current report
12/14/202318:00GLOBENeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
12/06/202315:24EDGAR2Form 425 - Prospectuses and communications, business..
12/06/202315:21EDGAR2Form 8-K - Current report
12/04/202316:14EDGAR2Form 425 - Prospectuses and communications, business..
12/04/202316:10EDGAR2Form 8-K - Current report
11/30/202315:06EDGAR2Form 425 - Prospectuses and communications, business..
11/08/202313:34EDGAR2Form S-4/A - Registration of securities, business..
10/18/202315:09EDGAR2Form S-4/A - Registration of securities, business..
10/05/202311:50EDGAR2Form 425 - Prospectuses and communications, business..
9/28/202315:28EDGAR2Form S-4/A - Registration of securities, business..

Your Recent History

Delayed Upgrade Clock